Evidence map›Paper›PMID 41650799›Full record

ArticleDrug and alcohol dependence2026

Perspectives on collaboration between drug courts and MOUD providers: Impact of interagency implementation strategies.

Ekaterina Pivovarova, Faye S Taxman, Barbara Andraka-Christou, Alexandra Boland, Dara Drawbridge, David Smelson, Stephenie C Lemon, Peter D Friedmann

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ekaterina PivovarovaDepartment of Family Medicine and Community Health, University of Massachusetts Chan Medical School, Worcester, MA, USA. Electronic address: ekaterina.pivovarova@umassmed.edu.
Faye S TaxmanSchar School of Policy and Government, George Mason University, Fairfax, VA, USA. Electronic address: ftaxman@gmu.edu.
Barbara Andraka-ChristouSchool of Global Health Management and Informatics, College of Community Innovation and Education, University of Central Florida, Orlando, USA. Electronic address: Barbara.Andraka@ucf.edu.
Alexandra BolandDepartment of Family Medicine and Community Health, University of Massachusetts Chan Medical School, Worcester, MA, USA. Electronic address: Alexandra.boland@umassmed.edu.
Dara DrawbridgeDepartment of Psychiatry, Center of Excellence for Specialty Courts, University of Massachusetts Medical School, 222 Maple Ave, Chang Building, UMass Chan, Shrewsbury, MA, USA. Electronic address: dara.drawbridge@umassmed.edu.
David SmelsonDepartment of Medicine, Division of Health Systems Sciences, University of Massachusetts Chan Medical School, Worcester, MA, USA. Electronic address: david.smelson@umassmed.edu.
Stephenie C LemonDivision of Preventive and Behavioral Medicine, Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA, USA. Electronic address: Stephenie.lemon@umassmed.edu.
Peter D FriedmannDepartment of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA, USA. Electronic address: peter.friedmann3@umassmed.edu.

Funding

Increasing Referrals to Medications for Opioid Use Disorders from Drug Treatment Courts using Organizational Linkage InterventionK23DA049953 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PIVOVAROVA, EKATERINA · 2020 to 2022
$612k
NIDA NIH HHS K23 DA049953
6 · The paper itself

Abstract

backgroundEffective working relationships between drug courts and community providers are critical to improving access to medications for opioid use disorder (MOUD), but collaboration is often inadequate. We adapted and piloted a package of implementation strategies (Clinical Organizations and Legal Agency Alliance Building; COLAAB) designed to enhance collaboration between recovery courts and MOUD agencies. COLAAB activities included structured interagency meetings, agency tours, academic liaison, and development of local resource guides.

methodsAfter the implementation of COLAAB in three courts, we conducted semi-structured interviews (n = 24) with drug court and MOUD staff to assess the impact of COLAAB on collaboration, communication, and referrals. Data were analyzed using a modified iterative categorization approach.

resultsDrug court and MOUD agency staff perceived COLAAB as facilitating interagency relationships and referrals to MOUD, increasing MOUD agencies' understanding of drug courts, improving communication quality, strengthening understanding and trust in MOUD providers and drug courts, and reducing time to referrals to MOUD. COLAAB also increased the MOUD agency staff's awareness of other community providers and helped build their potential referral networks. COLAAB may have also enhanced drug court staff's willingness to speak with clients about MOUD and MOUD provider staff's willingness to discuss clients' criminal legal involvement. DISCUSSION: Our pilot study provides preliminary evidence that court-MOUD agency collaborations can be enhanced through active learning about one another's practices and services, participation in regularly scheduled meetings or activities, and the identification and use of resources that support efficient interagency referral processes.

Indexed as

CollaborationCriminal legal systemDrug courtsImplementation strategiesMedications for opioid use disorderMOUDSubstance use disorder

Identifiers

PMID41650799
PMCPMC12989121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.